Option Care 研究：由营养师管理的家庭营养患者更有可能接受到符合指导方针要求的治疗
By: Option Care
January 17, 2016
AUSTIN, Texas, Jan. 17, 2016 — Patients are more likely to receive the appropriate type of home nutrition therapy when their care includes management by registered dietitians, suggests a study being presented at the American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.) Clinical Nutrition Week meeting today in Austin.
Nutrition therapy patients receiving home parenteral (intravenous) nutrition (HPN) were transitioned to home enteral (through a feeding tube) nutrition (HEN) or to an oral diet sooner due to the registered dietitians’ expertise and adherence to A.S.P.E.N. guidelines, researchers found. Patients with a variety of health conditions require nutrition support: the guidelines generally recommend HPN for patients whose gastrointestinal (G.I.) systems aren’t functioning, and HEN for those whose G.I. systems are functioning, but who may have other problems that interfere with eating, such as the inability to swallow. HEN is preferable whenever possible because it is more similar to how the body naturally receives nutrition.
指南指出，使用 HPN 的患者应在胃肠功能正常运作时，立即转为 HEN 或口服饮食。HPN 不仅成本更高，而且与 HEN 相比，感染的风险明显更高。营养处方可由医师或注册营养师管理，也可由两者协作管理。研究人员发现，在为期五年的研究中，注册营养师管理的患者比例有所增加，而接受 HPN 治疗的患者平均天数减少了，这表明患者较早告别了 HPN 治疗。
“Clearly, home nutrition patients benefit from care provided by a dietitian-led nutrition support team,” said Kelly Kinnare, MS, RD, LDN, CNSC, nutrition services manager for Option Care. “Physicians are busy and recognize the expertise dietitians provide and therefore increasingly are putting the nutrition order writing and weaning recommendations in our hands. “
此项研究包括 505 名从 2010 年 1 月 1 日至 2014 年 12 月 31 日期间开始接受 HPN 治疗的患者。在此期间，由注册营养师管理的病人比例增加了 18%（从 75% 上升到 91%），而接受 HPN 治疗的患者平均天数减少了 33%（从 128.7 天减少到 86.5 天）。
“HPN is more invasive, presents with serious complications, and is significantly more expensive than HEN therefore should only be utilized when appropriate,” said Noreen Luszcz, RD, MBA, CNSC, nutrition program director for Option Care. “While HEN costs about $500 a month per patient, HPN is 10 times as expensive, costing about $5,000 a month. “
在这项研究中，每名患者接受 HPN 治疗的平均时长减少了 42 天，营养师管理则有所增加。每名患者减少了 42 天的 HPN 治疗相当于节省了 7,000 美元的医疗保健费用，这还不包括消除潜在的管路感染及其他与 HPN 相关的并发症所需的费用。
Option Care 的营养支持项目遵循一个多学科团队的护理方法，该团队包括输液护士、药剂师和获得营养支持认证的营养师，他们与医师密切合作，为 HPN 和 HEN 患者提供优质的护理。此项目在其 92 家输液药房中每家都配备了一名注册营养师。
患者被开出 HPN 或 HEN 的处方，是因为他们具有如癌症、中风、胃肠道疾病或手术并发症等病症，无法通过口服来满足他们的营养需求。虽然这两种疗法可以在医院进行临时施用，但每年大约有 40,000 名 HPN 患者和 344,000 名 HEN 患者在家中安全地接受营养治疗，费用更低，避免了医院获得性感染的风险，可重返工作并且过着积极向上的生活。尽管有些人是短期接受这些治疗，但许多人的治疗时间更长，有些甚至是终生治疗。
关于 Option Care
Option Care Enterprises, Inc. 由经过专门培训的输液护士、药剂师和营养师提供临床护理，医治各式急性、慢性和罕见疾病的患者。作为全美最大的家庭和备选医疗站点输液服务提供者之一，Option Care 在美国各地拥有 92 家输液药房和 110 个备选医疗站点。有关详情请访问 www.OptionCare.com。
# # #
媒体联系人信息
Option Care
Lauren Kotarski
312-558-1770
LKotarski@pcipr.com
You might also be interested in:
Option Care 数据的新研究表明，接受正性肌力药物治疗家庭输液的心力衰竭患者在结合指导方针导向药物治疗的情况下，生存率有所提高
BANNOCKBURN, Ill., May 16, 2018 — Survival may improve when advanced heart failure patients receiving home infusion of inotropic therapy are also receiving guideline-directed care, suggest results of a large study recently published in The Journal of Heart and Lung Transplantation. The study was conducted by investigators from Keck School of Medicine of USC and Option […]
Option Care，20 多年来获得 FDA 批准的第一种 ALS 药物的全国性家庭输液服务提供者
BANNOCKBURN, Ill., Sept. 6, 2017 — Option Care Enterprises, Inc., the nation’s largest independent provider of home and alternate treatment site infusion services, has signed an agreement to become a national contracted home infusion provider for ALS drug RADICAVATM (edaravone), an intravenous (IV) infusion treatment for amyotrophic lateral sclerosis (ALS). RADICAVA, the first ALS treatment […]